| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.8M | — | +24.4% |
| R&D Expense | $17.6M | — | +73.2% |
| SG&A Expense | $12.4M | — | +359.0% |
| Operating Income | -$37.9M | +2.2% | -1299.0% |
| Pre-tax Income | $26.5M | — | +120.7% |
| Income Tax | -$4K | — | -500.0% |
| Net Income | $26.5M | — | +785.1% |
| EPS (Basic) | $0.12 | — | +105.6% |
| EPS (Diluted) | $0.10 | — | +104.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $65.0M | +28.0% | +9781.1% |
| Accounts Receivable | $500K | -43.1% | — |
| Current Assets | $95.3M | -24.3% | — |
| Total Assets | $130.8M | -17.9% | -76.5% |
| Current Liabilities | $25.9M | -3.0% | +736.3% |
| Long-term Debt | $29.8M | -0.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$29.5M | — | -9174.7% |
| Capital Expenditures | $5.5M | — | +138.4% |
| Investing Cash Flow | $39.5M | — | +1801.3% |
| Financing Cash Flow | $4.2M | — | -78.7% |
| Free Cash Flow | -$35.0M | — | -1227.7% |
| +495.0% |
| Total Liabilities | $153.6M | -30.0% | +500.0% |
| Stockholders' Equity | -$245.9M | +13.1% | -893.8% |